Dergi makalesi Açık Erişim
Erdogar, Nazli; Akkin, Safiye; Nielsen, Thorbjorn T.; Ozcelebi, Esin; Erdogdu, Batuhan; Nemutlu, Emirhan; Iskit, Alper B.; Bilensoy, Erem
Purpose Aprepitant (APRT), a selective neurokinin 1 antagonist, is clinically used in the prevention of acute and delayed chemotherapy-induced nausea and vomiting. The low solubility of APRT, which limits its oral bioavailability, is overcome by nanonization. This study aimed to design and evaluate novel in vitro and in vivo chitosan (CS)-polyethylene glycol (PEG)-coated cyclodextrin (CD) nanoparticles and nanocapsules to enhance the solubility and oral bioavailability of APRT.
Dosya adı | Boyutu | |
---|---|---|
bib-0b420214-936d-4182-aa3b-c99e882f4bc9.txt
md5:169c8f55676c326d7ae1976c59947048 |
330 Bytes | İndir |
Görüntülenme | 46 |
İndirme | 7 |
Veri hacmi | 2.3 kB |
Tekil görüntülenme | 45 |
Tekil indirme | 7 |